Nothing sinister that I know but am curious as if it is a change across the board on rules other companies would also be doing the same update. Ones I look at haven't or I haven't noticed. I'm not sure if a new rule came in or a deadline at 1st July like so much other legislation nor why a company would leave it so late in that case. The only sinister bit would that ASIC often does side agreements when there has been poor reporting by companies or poor execution of duties and then the company agrees ( private undertaking) to better process and puts out a announcement. What pricked my interest was that there was no explanation along with the updated rules. Not sure why they wouldn't do a 2 liner covering letter saying that it was a requirement to meet XX rule . I always worry when Co put out the bare minimum of detail or something left field that others aren't. What made me ask was the big who ha going on about CBA and it's financial planners and how ASIC and govt were waiting for CBA to announce something rather than tell them what they have to do. When ASIC or Hockey were asked they also let slip that Macquarie Private ( I think) had entered into a private undertaking rather than fines or disciplinary process and yet Maq Private clients seem non the wiser. I don't like things behind closed doors and things that are kept quiet as it goes to management quality and trust. Would you use Maq or CBA planners if you knew there was ongoing action in the background that they refuse to announce publicly and this has been agreed by ASIC. . My nose twitched and smelled something that was all and I posed the question as I don't know.
yeah a update wouldn't go astray.
- Forums
- ASX - By Stock
- ABV
- Ann: Updated securities trading policy
Ann: Updated securities trading policy, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ABV (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
-0.001(1.12%) |
Mkt cap ! $28.70M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 8.8¢ | $21.89K | 244.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8791 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 131787 | 0.012 |
1 | 100000 | 0.010 |
1 | 700561 | 0.009 |
2 | 10000000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 371498 | 2 |
0.015 | 528000 | 2 |
0.016 | 119374 | 2 |
0.017 | 687500 | 3 |
0.019 | 575000 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
ABV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online